250 Participants Needed

Mobile Health Cardiac Rehabilitation for Ischemia

JD
HR
Overseen ByHarmony Reynolds, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a multi-site phase II, 2:1 pragmatic randomized trial of 250 participants within the NYU Langone Health (NYULH) and Emory University Medical Center system to evaluate mobile health cardiac rehabilitation (mHealth-CR) in patients who meet clinical criteria for INOCA (ischemia and no obstructive coronary disease on imaging). Participants will be randomized to mHealth-CR or usual care. The study intervention takes place for 3 months which is the time period for most traditional CR programs. The overall study goals are threefold: 1) to evaluate whether an mHealth-CR intervention that includes activity tracking, weekly counseling, and exercise documentation, improves health status (i.e., symptoms, function, and quality of life) in patients with INOCA at 3 months; 2) to evaluate effects of the mHealth-CR intervention vs. usual care on physical activity and exercise capacity, general health status, and depressive symptoms (secondary endpoints). We will also evaluate effects on primary and secondary outcomes at 6 months and 1 year; and 3) to characterize engagement and elucidate any factors that limit engagement.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment mHealth-CR for ischemia?

Research shows that mobile health cardiac rehabilitation (mHealth-CR) can improve health-related quality of life and behavioral outcomes in patients recovering from heart issues like acute coronary syndrome. This suggests that using mobile technology to support cardiac rehabilitation can help patients manage their heart health better.12345

Is mobile health cardiac rehabilitation safe for humans?

The research does not specifically address safety concerns, but mobile health cardiac rehabilitation (mHealth-CR) is generally considered a way to improve access and participation in cardiac rehabilitation, which is known to be beneficial for heart health.25678

How is the mHealth-CR treatment different from other treatments for ischemia?

The mHealth-CR treatment is unique because it uses mobile technology to deliver cardiac rehabilitation remotely, allowing patients to engage in their rehabilitation from home. This approach can help overcome barriers like distance and accessibility, making it easier for patients to participate in their recovery process compared to traditional in-person cardiac rehabilitation programs.245910

Research Team

HR

Harmony Reynolds, MD

Principal Investigator

NYU Langone Health

Eligibility Criteria

This trial is for individuals with INOCA, which means they have symptoms of heart issues but no blocked arteries. They must be part of the NYU Langone Health or Emory University Medical Center system and willing to use a wearable device and communicate with an exercise therapist for 3 months.

Inclusion Criteria

I have INOCA diagnosed with a CT scan or angiography.

Exclusion Criteria

Pregnant
I regularly use a walker for mobility.
Unable to read and communicate in English since the app content is currently only available in English.
See 10 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive mHealth-CR intervention including activity tracking, weekly counseling, and exercise documentation for 3 months

12 weeks
Weekly phone calls

Follow-up

Participants are monitored for safety and effectiveness after treatment, with evaluations at 6 months and 1 year

9 months

Treatment Details

Interventions

  • mHealth-CR
Trial Overview The study tests if a mobile health cardiac rehab program (mHealth-CR), involving activity tracking, weekly counseling, and exercise documentation can improve symptoms, function, and life quality in INOCA patients compared to usual care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: mHealth-Cardiac Rehabilitation (CR)Experimental Treatment3 Interventions
Participants in the mHealth-CR arm will receive daily therapist-directed activity and weekly phone calls, use a mHealth-CR app to track activity, heart rate and access educational materials, and use a wearable wrist activity monitoring device (such as Fitbit or Apple Watch).
Group II: Usual CareActive Control1 Intervention
Participants in usual care arm will receive standard medical care as determined by their physician. They will also use a wearable wrist activity monitoring device.

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

The mobile health augmented cardiac rehabilitation (MCard) program significantly improved physical activity and healthy eating behaviors among post-acute coronary syndrome patients over a six-month period, with notable increases in healthy eating scores and reduced salt intake.
MCard was shown to be a feasible intervention that led to lasting behavior modifications in patients, although it did not significantly affect medication compliance, smoking behavior, or self-monitoring of blood pressure and weight.
Effectiveness of Mobile Health Augmented Cardiac Rehabilitation on Behavioural Outcomes among Post-acute Coronary Syndrome Patients: A Randomised Controlled Trial.Manzoor, S., Hisam, A., Aziz, S., et al.[2021]
A survey of 74 adults with cardiovascular disease showed that 95% owned mobile phones and 77% were interested in receiving cardiac rehabilitation information via text messages, indicating a strong potential for mobile technology to enhance CR attendance.
A pilot study with 20 participants revealed that a 4-week healthy eating program delivered through mobile technology significantly improved self-efficacy related to heart-healthy eating, particularly in environmental self-efficacy, suggesting that text messaging is an effective method for delivering nutrition information.
Cardiovascular Disease Self-Management: Pilot Testing of an mHealth Healthy Eating Program.Dale, LP., Whittaker, R., Eyles, H., et al.[2022]
The study will evaluate the effectiveness of a mobile health augmented cardiac rehabilitation program (MCard) over 23-24 weeks for improving health-related quality of life (HRQoL) and clinical outcomes in 160 post-acute coronary syndrome (ACS) patients.
If successful, MCard could provide a cost-effective and resource-efficient rehabilitation option that can be scaled to other cardiac centers, especially important during the COVID-19 pandemic.
Mobile Health Augmented Cardiac Rehabilitation (MCard) in Post-Acute Coronary Syndrome Patients: A randomised controlled trial protocol.Hisam, A., Haq, ZU., Khan, Z., et al.[2022]

References

Effectiveness of Mobile Health Augmented Cardiac Rehabilitation on Behavioural Outcomes among Post-acute Coronary Syndrome Patients: A Randomised Controlled Trial. [2021]
Cardiovascular Disease Self-Management: Pilot Testing of an mHealth Healthy Eating Program. [2022]
Mobile Health Augmented Cardiac Rehabilitation (MCard) in Post-Acute Coronary Syndrome Patients: A randomised controlled trial protocol. [2022]
Effectiveness of Mobile Health Augmented Cardiac Rehabilitation (MCard) on health-related quality of life among post-acute coronary syndrome patients: A randomized controlled trial. [2022]
HEART: heart exercise and remote technologies: a randomized controlled trial study protocol. [2021]
A Structured Review of Commercially Available Cardiac Rehabilitation mHealth Applications Using the Mobile Application Rating Scale. [2023]
Effects of a patient-centered digital health intervention in patients referred to cardiac rehabilitation: the Smart HEART clinical trial. [2023]
Digital Technologies in Cardiac Rehabilitation: A Science Advisory From the American Heart Association. [2023]
Use of Smartphone Apps for Improving Physical Function Capacity in Cardiac Patient Rehabilitation: Systematic Review. [2023]
VA FitHeart, a Mobile App for Cardiac Rehabilitation: Usability Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity